Sector: Basic Materials | Industry: Agricultural Chemicals |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 4695 Macarthur Ct NEWPORT BEACH CA 92660-1882 |
Tel: | 1-949-2601200 |
Website: | https://www.american-vanguard.com |
IR: | See website |
Key People | ||
Eric G. Wintemute Chairman of the Board, Chief Executive Officer | David T. Johnson Chief Financial Officer, Vice President, Treasurer | Ulrich G. Trogele Executive Vice President, Chief Operating Officer of AMVAC Chemical Corporation |
Anthony S. Hendrix Senior Vice President - Crop Sales, U.S. and Canada | Shirin Khosravi Senior Vice President of Human Resources | Timothy J. Donnelly Chief Administrative Officer, General Counsel, Secretary |
Peter E. Eilers Managing Director of AMVAC Netherlands BV | Don Gualdoni Chief Transformation Officer |
Business Overview |
American Vanguard Corporation is a diversified specialty and agricultural products company. The Company develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. The Company conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC manufactures chemical, biological and biorational products that develop and markets solutions for agricultural, commercial and consumer uses. Its products include insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals, and are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. It also manufactures microbial cleaning products, BioMop-Plus and DrainGel. |
Financial Overview |
For the three months ended 31 March 2024, American Vanguard Corp. revenues increased 8% to $135.1M. Net income decreased 19% to $1.6M. Revenues reflect United States segment increase of 12% to $85M, International segment increase of 2% to $50.1M. Net income was offset by Other increase of 46% to $13.3M (expense), Interest Expense, net - Balancing value increase from $1.7M to $3.8M (expense). Dividend per share remained flat at $0.03. |
Employees: | 845 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $427.97M as of Mar 31, 2024 |
Annual revenue (TTM): | $589.63M as of Mar 31, 2024 |
EBITDA (TTM): | $49.91M as of Mar 31, 2024 |
Net annual income (TTM): | $7.15M as of Mar 31, 2024 |
Free cash flow (TTM): | -$76.14M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $173.31M as of Mar 31, 2024 |
Shares outstanding: | 27,984,744 as of Apr 29, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |